top of page


Gwenael Allan, a senior member of Cresswell Advisors, is the founder of Sensory Odyssey. SO provides a unique dimension in the life sciences being amongst the first worldwide to utilize olfactory senses to stimulate neural responses as additions to visual and aural appreciation of presentations.

The novelty and power of olfactory sensory stimulation will be presented  at the initial SO exhibition being launched by France’s prestigious and historied (created by King Louis XIII in 1635) Muséum national d'Histoire naturelle in 2021. 


SO’s exhibitions are expected to add real-life experiences to the research undertaken at sensory-specific academic organizations such as Philadelphia’s Monell Chemical Senses Center. That latter generates knowledge of the mechanisms and functions of the chemical senses relevant to issues related to public health, national health policy, and quality of life that experiences at SO’s exhibitions would help to validate. SO’s exhibitions will be rolled out internationally following the 2021 launch.  The brand has been established on four years of intensive research involving recognized names in the field including International Flavors and Fragrances. The organization is funded by private equity with the largest investor being the Caisse des dépôts et consignations, the investment arm of the French State.

Bruce H Chapman MSc. JD. Managing Director - Legal

Bruce Chapman is a widely-experienced corporate and tax lawyer, and a senior member at  Cresswell Advisors Inc. He has represented corporations and organizations internationally in a range of matters including intellectual property, specializing in Canadian tax law. He is proficient in French, Italian, Spanish and Mandarin.

He holds and MSc in applied mathematics from the California Institute of Technology JD, corporate law, securities and taxation specialization, from Harvard


Law School. Townsend & Townsend (now Townsend & Townsend & Crew LLP) , San Francisco, CA (intellectual property attorneys); Owen, Bird, Vancouver. BC (corporate law); Principal at Chapman& Company/Chapman Tax Law

Dr. Roges is an internationally-experienced MD and Senior Manager with more than 15 years of management expertise in drug development and clinical research for pharmaceutical companies and contract research organizations.

He was the Country Executive in Cuba for YM BioSciences, responsible for interaction with the principal Cuban scientific institutes, government relations with both the Government of Cuba and the officials of the Canadian Embassy in Havana, and analyses and recommendations regarding Cuban biopharmaceuticals in development.

German Roges.png

With skills in Medical Affairs, Good Clinical Practice, Regulatory Compliance, Clinical Trial Management, Business Planning and Science Liaison and Education, his previous experience of 18 years as a scientist and lecturer in Life Sciences is recognized.

Advisory for Biotech companies
bottom of page